Results 221 to 230 of about 37,410 (291)

Integrated radio-theranostics using a [⁸⁹Zr]Zr-/[¹⁷⁷Lu]Lu-labeled B7-H3 antibody-drug conjugate for prostate cancer. [PDF]

Theranostics
Qiu Y, Gu T, Wang T, Mulati Y, Sun X, Yang Q, Song L, Yuan T, Fan Y, Kang L, Cai W.   +10 more
europepmc   +1 more source

Boron‐embedded multifunctional nanoplatform toward potential combined boron neutron capture therapy and immunomodulation in glioma

Smart Molecules, EarlyView.
A brain‐targeting multifunctional nanoplatform (DM&Ce6@COF‐Ang) was engineered by employing boron‐enriched APTES‐COF‐1 as both the therapeutic boron agent and the nanocarrier co‐delivery of DMXAA and Ce6. This nanoplatform achieved synergistic tumor‐specific boron delivery, real‐time pharmacokinetic monitoring, and immunomodulation.
Yiming Liu, Xuejian Wang, Bangjian Li, Kun Shao, Jianlong Su, Yang Wang, Lin Cheng, Zhihao Wu, JinRong Li, Guanyi Zhang, Xu Wang, Yuxuan Zhang, Yuanhao Liu, Guangzhe Li   +13 more
wiley   +1 more source

Dosimetry Analysis of ¹⁷⁷Lu-PSMA-I&T in Patients with Low-Volume Oligometastatic Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the LUNAR Trial. [PDF]

J Nucl Med
Ells Z, Meyer C, Kimura K, Wilhalme H, Cao M, Ludwig VB, Unterrainer LM, Sennung D, Nabong R, Felix C, Valle LF, Daley A, Czernin J, Dahlbom M, Kishan AU, Calais J.   +15 more
europepmc   +1 more source

Tracking Photocatalytic Pathways With In Situ Surface‐Enhanced Raman Spectroscopy

Transformative Chemistry, EarlyView.
In situ SERS captures surface molecular fingerprints during photocatalysis, revealing transient intermediates, bond evolution, pathway selectivity, and charge‐coupled molecular transformation beyond catalyst‐ or product‐centered characterization. This review maps SERS‐active platforms and future site‐specific, time‐resolved, intelligent strategies for ...
Chenyang Gao, Wenqing Jiang, Aochi Liu, Yujiao Xie, Aiguo Wu, Jie Lin   +5 more
wiley   +1 more source

Erratum: Ultrasound-controlled MXene-based Schottky heterojunction improves anti-infection and osteogenesis properties: Erratum. [PDF]

Theranostics
Wang H, Mu N, He Y, Zhang X, Lei J, Yang C, Ma L, Gao Y.   +7 more
europepmc   +1 more source

Peptide‐directed nanovehicles enabling tumor‐selective ROS amplification and antitumor immunity

VIEW, EarlyView.
Cancer cells are vulnerable to oxidative stress, yet exploit immune tolerance to escape destruction. In contrast, their metabolic profile is markedly altered to support rapid proliferation, accompanied by elevated production of reactive oxygen species (ROS).
Manuela Calin, Galyna Bila, Ileana Manduteanu, Rostyslav Bilyy   +3 more
wiley   +1 more source

Advances in the application of nanoparticles for the diagnosis and treatment of diabetic cardiomyopathy. [PDF]

Front Cell Dev Biol
Feng J, Huang Y, He Y, Deng C, Jiang Z, Li Q, Li Y, Lan X, Xu Y.   +8 more
europepmc   +1 more source

Nanomedicine applications in lymphoma: Advancing precision diagnostics, targeted therapeutics, and prospective developments

VIEW, EarlyView.
Lymphoma is a group of blood cancers that can appear in lymph nodes, blood, bone marrow, spleen, liver, or the central nervous system, which makes drug delivery and disease monitoring difficult. This review summarizes how nanomedicine technologies may improve targeted treatment and imaging, while carefully separating approved or guideline‐supported ...
Mohd Ahmar Rauf, Yara Mashal, Afeefa Rao, Nasar Ata, Arun K. Iyer, Farhan Shah   +5 more
wiley   +1 more source

Radiocopper in BCMA-targeted immunotheranostics of myeloma. [PDF]

Theranostics
Ullrich M, Zarschler K, Kubeil M, Laube M, Pietzsch J, Belter B.   +5 more
europepmc   +1 more source

Progress in bone tissue engineering biomaterials: Development, challenges, and prospects

VIEW, EarlyView.
Scheme 1 Application of biomaterials in immunomodulation during bone tissue engineering. Abstract Bone defect repair remains a major clinical challenge in orthopedics. Over 2 million cases caused by trauma, tumors, and other factors occur annually, with large‐scale defects posing a particular bottleneck due to limited self‐healing capacity.
Yuanbin Zhang, Junlei Chai, Quanwei Ding, Luping Liu, Kejie Zhang, Jie Lin, Jianhua Zhang, Youju Huang   +7 more
wiley   +1 more source